A number of studies have demonstrated that SLIT2 is epigenetically silenced by hypermethylation of the promoter region in a broad spectrum of other tumors, such as lung, breast, glioma, colon, and cervical cancers, leading to inactivation of SLIT2 expression [29], [45], [46], [47]. This evidence concerns the gene SLIT2 and glioma.